Related Experiment Video
Updated: Jul 13, 2026

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
Published on: February 3, 2017
Cardioprotective repair through stem cell-based cardiopoiesis
1Marriott Heart Disease Research Program, Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA. behfar.atta@mayo.edu
Insights
Stem cell therapy offers new hope for ischemic heart disease, potentially shifting treatment from palliative to curative. Research focuses on enhancing stem cell homing and function for myocardial repair.
Area of Science:
- Cardiovascular Medicine
- Regenerative Medicine
- Genomics and Proteomics
Background:
- Ischemic heart disease (IHD) remains a global health crisis despite existing treatments.
- Current stem cell therapies show modest improvements in myocardial function post-infarction.
- Enhanced stem cell engraftment and targeted delivery are crucial for effective cardiac repair.
Purpose of the Study:
- To explore the potential of stem cell biology in transforming IHD treatment.
- To investigate the application of genomic and proteomic technologies in understanding cardiopoiesis.
- To identify strategies for recruiting cardiopoietic stem cells for myocardial repair and protection.
Main Methods:
- Review of recent advances in stem cell biology and clinical trial outcomes.
- Examination of genomic and proteomic technologies for deciphering cardiopoiesis.
- Analysis of methods for recruiting stem cells for cardiac repair.
Main Results:
- Stem cell therapy presents a paradigm shift towards potentially curative IHD treatments.
- Genomic and proteomic insights are key to understanding and manipulating cardiopoiesis.
- Targeted delivery of stem cells to diseased myocardium is an active area of research.
Conclusions:
- Stem cell therapy holds promise for transforming IHD management.
- Genomic and proteomic approaches are vital for advancing stem cell-based cardiac repair.
- Future research should focus on optimizing stem cell homing and function for cardioprotection.
Abstract:
Ischemic heart disease continues to progress at pandemic levels despite current preventive and therapeutic interventions. Recent advances in stem cell biology have provided the impetus for a paradigm shift in treatment options, potentially transforming palliative care into curative therapy. Although delivery of stem cells in clinical trials has resulted in a modest functional improvement of myocardial performance in the setting of infarction, ongoing efforts at the bench and bedside are taking place to increase stem cell propensity for engraftment and homing into diseased myocardium. The newest opportunity has arisen with the delivery of stem cells guided to execute the cardiac program. Here, we examine the recent application of genomic and proteomic technology to decipher the process of cardiopoiesis and to recruit cardiopoietic stem cells for cardioprotection and safe myocardial repair.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture

